The infiltration and functional regulation of eosinophils induced by TSLP promote the proliferation of cervical cancer cell

Cancer Letters

Volumn 364, Issue 2, 2015, Pages 106-117

  Xie, Feng ^a   Liu, Li Bing ^a,b   Shang, Wen Qing ^a   Chang, Kai Kai ^a   Meng, Yu Han ^a   Mei, Jie ^a   Yu, Jia Jun ^a   Li, Da Jin ^a   Li, Ming Qing ^a,c  

^a FUDAN UNIVERSITY   (China)

^b NANJING MEDICAL UNIVERSITY   (China)

^c FUDAN UNIVERSITY   (China)

Author keywords

CCL17; Cervical cancer cells; Eosinophils; Proliferation; TSLP

Indexed keywords

B7 ANTIGEN; CD86 ANTIGEN; CYCLINE; FAS ANTIGEN; FAS LIGAND; INTERLEUKIN 10; INTERLEUKIN 13; INTERLEUKIN 4; INTERLEUKIN 5; KI 67 ANTIGEN; PROTEIN BCL 2; THYMIC STROMAL LYMPHOPOIETIN; THYMUS AND ACTIVATION REGULATED CHEMOKINE; CYTOKINE;

ADULT; APOPTOSIS; ARTICLE; CELL DIFFERENTIATION; CELL INFILTRATION; CELL INTERACTION; CELL PROLIFERATION; CELL SURVIVAL; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOKINE PRODUCTION; EOSINOPHIL; FEMALE; HELA CELL LINE; HUMAN; HUMAN TISSUE; HYPOXIA; LEUKOCYTE FUNCTION; MOLECULAR PATHOLOGY; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN SECRETION; UTERINE CERVIX CANCER; BIOSYNTHESIS; CELL COMMUNICATION; CELL GROWTH; CELL HYPOXIA; DISEASE COURSE; IMMUNOLOGY; MIDDLE AGED; PATHOLOGY; PHYSIOLOGY; SECRETION (PROCESS); UTERINE CERVIX TUMOR;

ADULT; APOPTOSIS; CELL COMMUNICATION; CELL GROWTH PROCESSES; CELL HYPOXIA; CYTOKINES; DISEASE PROGRESSION; EOSINOPHILS; FEMALE; HELA CELLS; HUMANS; MIDDLE AGED; UTERINE CERVICAL NEOPLASMS;

EID: 84930089377     PISSN: 03043835     EISSN: 18727980     Source Type: Journal    
DOI: 10.1016/j.canlet.2015.04.029     Document Type: Article

References (39)

1. Davis B.P., Rothenberg M.E. Eosinophils and cancer. Cancer. Immunol. Res 2014, 2:1-8.
2. Cormier S.A., Taranova A.G., Bedient C., Nguyen T., Protheroe C., et al. Pivotal advance: eosinophil infiltration of solid tumors is an early and persistent inflammatory host response. J. Leukoc. Biol 2006, 79:1131-1139.
3. Stenfeldt A.L., Wenneras C. Danger signals derived from stressed and necrotic epithelial cells activate human eosinophils. Immunology 2004, 112:605-614.
4. Facciabene A., Peng X., Hagemann I.S., Balint K., Barchetti A., Wang L.P., et al. Tumour hypoxia promotes tolerance and angiogenesis via CCL28 and T(reg) cells. Nature 2011, 475:226-230.
5. Caruso R.A., Parisi A., Quattrocchi E., Scardigno M., Branca G., Parisi C., et al. Ultrastructural descriptions of heterotypic aggregation between eosinophils and tumor cells in human gastric carcinomas. Ultrastruct. Pathol 2011, 35:145-149.
6. Horiuchi K., Mishima K., Ohsawa M., Sugimura M., Aozasa K. Prognostic factors for well-differentiated squamous cell carcinoma in the oral cavity with emphasis on immunohistochemical evaluation. J. Surg. Oncol 1993, 53:92-96.
7. Spiegel G.W., Ashraf M., Brooks J.J. Eosinophils as a marker for invasion in cervical squamous neoplastic lesions. Int. J. Gynecol. Pathol 2002, 21:117-124.
8. da Silva J.M., Queiroz-Junior C.M., Batista A.C., Rachid M.A., Teixeira M.M., da Silva T.A. Eosinophil depletion protects mice from tongue squamous cell carcinoma induced by 4-nitroquinoline-1-oxide. Histol. Histopathol 2014, 29:387-396.
9. Pedroza-Gonzalez A., Xu K., Wu T.C., Aspord C., Tindle S., Marches F., et al. Thymic stromal lymphopoietin fosters human breast tumor growth by promoting type 2 inflammation. J. Exp. Med 2011, 208:479-490.
10. Noti M., Wojno E.D., Kim B.S., Siracusa M.C., Giacomin P.R., Nair M.G., et al. Thymic stromal lymphopoietin-elicited basophil responses promote eosinophilic esophagitis. Nat. Med 2013, 19:1005-1013.
11. Xie F., Meng Y.H., Liu L.B., Chang K.K., Li H., Li M.Q., et al. Cervical carcinoma cells stimulate the angiogenesis through TSLP promoting growth and activation of vascular endothelial cells. Am. J. Reprod. Immunol 2013, 70:69-79.
12. Baltus B., Buitenhuis M., van Dijk T.B., Vinson C., Raaijmakers J.A., Lammers J.W., et al. C/EBP regulates the promoter of the eosinophil-derived neurotoxin/RNS2 gene in human eosinophilic cells. J. Leukoc. Biol 1999, 66:683-688.
13. Fridlender Z.G., Simon H.U., Shalit M. Metastatic carcinoma presenting with concomitant eosinophilia and thromboembolism. Am. J. Med. Sci 2003, 326:98-101.
14. Dibbert B., Daigle I., Braun D., Schranz C., Weber M., Blaser K., et al. Role for Bcl-xL in delayed eosinophil apoptosis mediated by granulocyte-macrophage colony-stimulating factor and interleukin-5. Blood 1998, 92:778-783.
15. Thielen C., Radermacher V., Trimeche M., Roufosse F., Goldman M., Boniver J., et al. TARC and IL-5 expression correlates with tissue eosinophilia in peripheral T-cell lymphomas. Leuk. Res 2008, 32:1431-1438.
16. Rothenberg M.E., Hogan S.P. The eosinophil. Annu. Rev. Immunol 2006, 24:147-174.
17. Rosenberg H.F., Dyer K.D., Foster P.S. Eosinophils: changing perspectives in health and disease. Nat. Rev. Immunol 2013, 13:9-22.
18. Ohkawara Y., Lim K.G., Xing Z., Glibetic M., Nakano K., Dolovich J., et al. CD40 expression by human peripheral blood eosinophils. J. Clin. Invest 1996, 97:1761-1766.
19. Woerly G., Roger N., Loiseau S., Dombrowicz D., Capron A., Capron M. Expression of CD28 and CD86 by human eosinophils and role in the secretion of type 1 cytokines (interleukin 2 and interferon gamma): inhibition by immunoglobulin a complexes. J. Exp. Med 1999, 190:487-495.
20. Bashir M.E.H., Louie S., Shi H.N., Nagler-Anderson C. Toll-like receptor 4 signaling by intestinal microbes influences susceptibility to food allergy. J. Immunol 2004, 172:6978-6987.
21. Ayhan A., Altintas A., Tuncer Z.S., Kucukali T., Yuce K. Prognostic value of mitotic activity, eosinophilic and inflammatory reaction in stage I cancer of the uterine cervix. Eur. J. Surg. Oncol 1992, 18:264-266.
22. Lorena S.C.M., Oliveira D.T., Dorta R.G., Landman G., Kowalski L.P. Eotaxin expression in oral squamous cell carcinomas with and without tumour associated tissue eosinophilia. Oral. Dis 2003, 9:279-283.
23. Teruya-Feldstein J., Jaffe E.S., Burd P.R., Kingma D.W., Setsuda J.E., Tosato G. Differential chemokine expression in tissues involved by Hodgkin's disease: direct correlation of eotaxin expression and tissue eosinophilia. Blood 1999, 93:2463-2470.
24. Sims J.E., Williams D.E., Morrissey P.J., Garka K., Foxworthe D., Price V., et al. Molecular cloning and biological characterization of a novel murine lymphoid growth factor. J. Exp. Med 2000, 92:671-680.
25. Liu Y.J. Thymic stromal lymphopoietin and OX40 ligand pathway in the initiation of dendritic cell-mediated allergic inflammation. J. Allergy. Clin. Immunol 2007, 120:238-244. quiz 245-246.
26. Liu Y.J., Soumelis V., Watanabe N., Ito T., Wang Y.H., Malefyt Rde W., et al. An epithelial cell cytokine that regulates T cell differentiation by conditioning dendritic cell maturation. Annu. Rev. Immunol 2007, 25:193-219.
27. Lotfi R., Lee J.J., Lotze M.T. Eosinophilic granulocytes and damage associated molecular pattern molecules (DAMPs): role in the inflammatory response within tumors. J. Immunother 2007, 30:16-28.
28. Gleich G.J., Adolphson C.R. The eosinophilic leukocyte: structure and function. Adv. Immunol 1986, 39:177-253.
29. Yang D., Chen Q., Su S.B., Zhang P., Kurosaka K., Caspi R.R., et al. Eosinophil-derived neurotoxin acts as an alarmin to activate the TLR2-MyD88 signal pathway in dendritic cells and enhances Th2 immune responses. J. Exp. Med 2008, 205:79-90.
30. Mattes J., Hulett M., Xie W., Hogan S., Rothenberg M.E., Foster P., et al. Immunotherapy of cytotoxic T cell-resistant tumors by T helper 2 cells: an eotaxin and STAT6-dependent process. J. Exp. Med 2003, 197:387-393.
31. Legrand F., Driss V., Delbeke M., Loiseau S., Hermann E., Dombrowicz D., et al. Human eosinophils exert TNF-a and granzyme A-mediated tumoricidal activity toward colon carcinoma cells. J. Immunol 2010, 185:7443-7451.
32. Kataoka S., Konishi Y., Nishio Y., Fujikawa-Adachi K., Tominaga A. Antitumor activity of eosinophils activated by IL-5 and eotaxin against hepatocellular carcinoma. DNA. Cell. Biol 2004, 23:549-560.
33. Munitz A., Bachelet I., Fraenkel S., Katz G., Mandelboim O., Simon H.U., et al. 2B4 (CD244) is expressed and functional on human eosinophils. J. Immunol 2005, 174:110-118.
34. Letterio J.J., Roberts A.B. Regulation of immune responses by TGF-beta. Annu. Rev. Immunol 1998, 16:137-161.
35. Puxeddu I., Alian A., Piliponsky A.M., Ribatti D., Panet A., Levi-Schaffer F. Human peripheral blood eosinophils induce angiogenesis. Int. J. Biochem. Cell Biol 2005, 37:628-636.
36. Munitz A., Levi-Schaffer F. Eosinophils: 'new' roles for 'old' cells. Allergy 2004, 59:268-275.
37. Salcedo R., Young H.A., Ponce M.L., Ward J.M., Kleinman H.K., Murphy W.J., et al. Eotaxin (CCL11) induces in vivo angiogenic responses by human CCR3+ endothelial cells. J. Immunol 2001, 166:7571-7578.
38. Foster P.S., Hogan S.P., Ramsay A.J., Matthaei K.I., Young I.G. Interleukin 5 deficiency abolishes eosinophilia, airways hyperreactivity, and lung damage in a mouse asthma model. J. Exp. Med 1996, 183:195-201.
39. Tepper R.I., Coffman R.L., Leder P. An eosinophil-dependent mechanism for the antitumor effect of interleukin-4. Science 1992, 257:548-551.